In-Ear EEG Wearable Could Enable Home Brain Monitoring

The NeuroBuds, which resemble a hearing aid, record brain activity for up to three months without a technician-applied cap.

Updated on Nov. 3, 2026 in Stroke

Flat vector editorial illustration of a single smooth in-ear device with a slim curved stem on a cream field, teal and coral accents, representing a home brain-monitoring wearable.
Cebreo Medical received CE marking for its NeuroBuds, an in-ear EEG device that records brain activity at home for up to three months. AI Illustration. Upload story photo >

Live Poll

Would you be willing to use an at-home wearable for long-term medical monitoring?

Cebreo Medical has received CE marking for its NeuroBuds, an in-ear EEG wearable designed for extended home monitoring. The company plans to expand commercial availability across European research and clinical sites, with a US regulatory pathway in development.

Why it matters

Long-term EEG monitoring has traditionally required a technician-applied electrode cap in a clinical setting, which can be burdensome and stigmatizing for patients. A device that patients can use unassisted in their daily lives could make extended brain-activity monitoring more practical for people being evaluated for neurological conditions.

The announcement is based on the CE marking award and manufacturer descriptions of the device rather than published clinical trial data. Performance claims such as multi-day and multi-night recording in a home environment have not been quantified in the source.

The players

Cebreo Medical

The developer of the NeuroBuds in-ear EEG wearable, seeking to expand commercial availability in Europe and advance a US regulatory pathway.

The details

The NeuroBuds sit in the ear and resemble a hearing aid, which the company designed to reduce the stigma and physical burden associated with long-term EEG. Because the patient can use the device unassisted at home, it can record brain electrical activity across multiple days and nights in everyday surroundings. Repeated measurements over up to three months can capture patterns that a single short clinic visit may miss.

Timeline

  1. Article on the CE marking of NeuroBuds published November 3, 2026

  2. Cebreo Medical plans to expand commercial availability across European research and clinical sites, with no date given

  3. Cebreo Medical plans to advance its US regulatory pathway, with no date given

Health Landscape

Long-term EEG monitoring has depended on clinic-based electrode caps applied by technicians, limiting how long and where brain activity can be recorded. Wearable approaches such as the NeuroBuds aim to shift that model toward home-based, extended ambulatory monitoring.

If you have been advised to undergo prolonged brain-activity monitoring, it may be worth asking your neurologist whether home-based options could be appropriate for your situation. Patients should not assume a device is available in their country until local regulatory approval and clinical availability are confirmed.

The takeaway

Wearable EEG devices may make extended brain monitoring more practical outside the clinic. Ask your physician whether ambulatory monitoring is part of any evaluation you are undergoing, and confirm local availability before planning around a new device.

Further reading

For more on the conditions that long-term brain monitoring helps evaluate, explore our Stroke coverage.

Source note: This article includes information reported by Sleep Review.

Live Poll

Would you be willing to use an at-home wearable for long-term medical monitoring?